Commercialization of TDM-644 through Reimbursement Listing and Hemostatic Product Cross-Selling
A commercialization initiative for approved TDM-644 that aims to secure reimbursement coverage while establishing a sales platform through cross-selling with existing hemostatic products.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.